MedTrace Logo

A Clinical Trial to Evaluate the Effects of a Supplement on Markers of Male Fertility

NCT07740161 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 40

Last updated 2026-07-31

No results posted yet for this study

Summary

This study will evaluate the effects of the WeNatal For Him supplement on markers of male fertility over a 3-month period. The trial is a single-arm, unblinded study enrolling 40 male participants who will take 3 capsules of the test product daily in the morning with their first meal.

Participants will complete questionnaires at Baseline, Month 1, Month 2, and Month 3. Semen analysis will be conducted at home at Baseline and Month 3, and blood testing will be performed at a local Labcorp location at Baseline and Month 3. The primary focus is on sperm quality parameters and testosterone levels, while secondary endpoints capture participants' perceptions of changes in reproductive and sexual health, including energy and libido.

Conditions

  • Male Infertility
  • Low Sperm Quality
  • Low Testosterone
  • Low Energy
  • Low Libido

Interventions

DIETARY_SUPPLEMENT

WeNatal For Him Supplement

All participants take 3 capsules of the WeNatal For Him supplement daily in the morning with their first meal for 3 months.

Sponsors & Collaborators

  • Citruslabs

    collaborator INDUSTRY

  • WeNatal

    lead INDUSTRY

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
30 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2025-04-14
Primary Completion
2025-09-15
Completion
2025-09-15

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07740161 on ClinicalTrials.gov